Lacosamide
NDC 0121-4048, Lacosamide, solution, from PAI Holdings, LLC dba PAI Pharma.
- Product NDC
- 0121-4048
- Status
- Listed
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216151
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/0121-4048 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE200 mg/20mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0121-4048-95 | 00121404895 | 1 TRAY in 1 CASE (0121-4048-95) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-4048-74) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/75de00d8-d2e7-4025-be4e-f49299068e7eNADAC price for package 00121404895
GET /v1/drugs/nadac/00121404895
Use it
Look up 0121-4048 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0121-4048 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0121-4048. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.